Lysophosphatidylcholine and Amide as Metabolites for Detecting Alzheimer Disease Using Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry–Based Metabonomics

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2014-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/NEN.0000000000000116PMID 25192049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal and Astrocytic Metabolism in a Transgenic Rat Model of Alzheimer's Disease

  2014cited by this paper
• Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

  2013cited by this paper
• Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.

  2012influential reference
• Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

  2011cited by this paper
• Argininosuccinate lyase deficiency—Argininosuccinic aciduria and beyond

  2011cited by this paper
• [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].

  2011cited by this paper
• [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].

  2011cited by this paper
• Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.

  2010cited by this paper
• L-Glutamine inhibits beta-aminobutyric acid-induced stress resistance and priming in Arabidopsis

  2009cited by this paper
• Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease

  2009cited by this paper
• Alzheimer’s Disease and Mild Cognitive Impairment

  2009cited by this paper
• Metabolomic profiling to develop blood biomarkers for Parkinson's disease.

  2008cited by this paper
• Metabonomic Characterization of The Low-grade Human Astrocytomas and Meningiomas Using Magic-angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy and Principal Component Analysis

  2008cited by this paper
• DNA immunization perturbs lipid metabolites and increases risk of atherogenesis.

  2008cited by this paper
• In the Rat Brain Acetyl-l-carnitine Treatment Modulates the Expression of Genes Involved in Neuronal Ceroid Lipofuscinosis

  2008cited by this paper
• Metabolomics identifies perturbations in human disorders of propionate metabolism.

  2007cited by this paper
• Endocannabinoids and Traumatic Brain Injury

  2007cited by this paper
• Natural antioxidants in Alzheimer's disease

  2007cited by this paper
• Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila.

  2007cited by this paper
• Metabolomics: available results, current research projects in breast cancer, and future applications.

  2007cited by this paper
• Alzheimer's disease and mild cognitive impairment.

  2007cited by this paper
• An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate.

  2006cited by this paper
• Cholesterol as a risk factor for Alzheimer's disease – epidemiological evidence

  2006cited by this paper
• Metabonomics: a Revolution in Progress

  2006cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu.

  2005cited by this paper
• Cholesterol in Alzheimer's disease.

  2005cited by this paper
• Gamma-D-glutamylglycine and cis-2,3-piperidine dicarboxylate as antagonists of excitatory amino acids in the hippocampus

  2004cited by this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cited by this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cited by this paper
• Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

  2003cited by this paper
• Alzheimer disease in the US population: prevalence estimates using the 2000 census.

  2003influential reference
• Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

  2002cited by this paper
• Metabonomic assessment of toxicity of 4‐fluoroaniline, 3,5‐difluoroaniline and 2‐fluoro‐4‐methylaniline to the earthworm Eisenia veneta (rosa): Identification of new endogenous biomarkers

  2002cited by this paper
• Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

  2002cited by this paper
• The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

  2002cited by this paper
• Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD‐Like Pathology in Aged Transgenic Mice

  2002cited by this paper
• Acute neuronal injury, excitotoxicity, and the endocannabinoid system

  2002cited by this paper
• Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

  2000cited by this paper
• 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.

  1999cited by this paper
• Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity

  1998cited by this paper
• Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

  1997influential reference
• Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study.

  1996cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Gas chromatographic retention indices of twenty metabolically important acylglycines as trimethylsilyl derivatives.

  1980cited by this paper

• Phospholipid biomarkers in the diagnosis of patients with Alzheimer's disease

  2026influential citation
• Guardians of Homeostasis: Natural Products Target Metabolic Reprogramming in Alzheimer's Disease.

  2025cites this paper
• Lysophosphatidylcholines are associated with amyloidosis in early stages of Alzheimer’s disease

  2025cites this paper
• Low Plasma Lysophosphatidylcholine Levels Are Associated With Reduced Handgrip Strength in Older Outpatients

  2025cites this paper
• Comprehensive metabolomics profiling reveals novel biomarkers and pathways for early detection of Alzheimer’s disease

  2025cites this paper
• Lipidomic and transcriptomic profiling reveal alterations in the coexistence of gestational diabetes mellitus and preeclampsia impacting maternal and neonatal outcomes

  2025cites this paper
• A long-term mild high-fat diet facilitates rabbit discrimination learning and alters glycerophospholipid metabolism.

  2025cites this paper
• Maternal Exposure to Polypropylene Nanoplastics Disrupts Sex- and Region-Specific Lipid Metabolism in the Brains of C57BL/6N Mouse Offspring.

  2025cites this paper
• Enhanced Microglial Engulfment of Dopaminergic Synapses Induces Parkinson's Disease‐Related Executive Dysfunction in an Acute LPC Infusion Targeting the mPFC

  2025cites this paper
• Mapping the lipidome in mitochondria‐associated membranes (MAMs) in an in vitro model of Alzheimer's disease

  2024cites this paper
• Urine biomarkers for Alzheimer's disease: A new opportunity for wastewater-based epidemiology?

  2024cites this paper
• Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s Disease

  2024cites this paper
• Comprehensive chemical profiling with UHPLC-MS, in-vitro, in-silico, and in-vivo antidiabetic potential of Typha domingensis Pers; A novel source of bioactive compounds

  2024cites this paper
• A Metabolomics Analysis of a Novel Phenotype of Older Adults at Higher Risk of Dementia

  2023cites this paper
• Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s Disease

  2023cites this paper
• Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence.

  2023cites this paper
• Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels

  2023cites this paper
• Advances in peripheral blood biomarkers of patients with Alzheimer's disease: Moving closer to personalized therapies.

  2023cites this paper
• Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer’s Disease and Subcortical Cerebrovascular Disease

  2023cites this paper
• Protective effect of kaempferol against cognitive and neurological disturbances induced by d-galactose and aluminum chloride in mice

  2023cites this paper
• Pterostilbene could alleviate diabetic cognitive impairment by suppressing TLR4/NF‐кB pathway through microbiota‐gut‐brain axis

  2023cites this paper
• Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy

  2023cites this paper
• Rapid and Sensitive Detection of Lysophosphatidylcholine Using Zwitterionic Polydiacetylene Vesicles and a Microfluidic Gradient Sensor

  2022cites this paper
• Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells

  2022cites this paper
• Insulin resistance in Alzheimer's disease: The genetics and metabolomics links.

  2022cites this paper
• Developmental programming: Preconceptional and gestational exposure of sheep to a real-life environmental chemical mixture alters maternal metabolome in a fetal sex-specific manner.

  2022cites this paper
• Nutritional metabolism and cerebral bioenergetics in Alzheimer’s disease and related dementias

  2022cites this paper
• Spirulina platensis Suppressed iNOS and Proinflammatory Cytokines in Lipopolysaccharide-Induced BV2 Microglia

  2022cites this paper
• Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease

  2022cites this paper
• Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice

  2022cites this paper
• Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis

  2022cites this paper
• Comments on: Huang S. et al. “Biofluid Biomarkers of Alzheimer's disease: Progress, problems, and perspectives.” Neuroscience Bulletin (2022)

  2022cites this paper
• Multi-Timepoint Metabolic Fingerprinting of a Post-Episode Period of Hypoglycemia and Ketoacidosis Among Children With Type 1 Diabetes

  2022cites this paper
• A multi‐omics analysis for the prediction of neurocognitive disorders risk among the elderly in Macao

  2022cites this paper
• Recent advances in LC-MS-based metabolomics for clinical biomarker discovery.

  2022cites this paper
• Multi-factor combined biomarker screening strategy to rapidly diagnose Alzheimer's disease and evaluate drug effect based on a rat model

  2022cites this paper
• Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin

  2021cites this paper
• Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Signals in Host–Microbe Interplay

  2021cites this paper
• Changes in Plasma Phospholipids and Sphingomyelins with Aging in Men and Women: A Comprehensive Systematic Review of Longitudinal Cohort Studies.

  2021cites this paper
• Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson’s disease

  2021cites this paper
• A UPLC-Q-TOF/MS-Based Metabolomics Study on the Effect of Corallodiscus flabellatus (Craib) B. L. Burtt Extract on Alzheimer's Disease

  2021cites this paper
• Pharmacokinetic and metabolomics approach based on UHPLC-MS to evaluate therapeutic effect of lignans from S. Chinensis in alzheimer's disease.

  2021cites this paper
• Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model

  2021cites this paper
• Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study

  2021cites this paper
• Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

  2021cites this paper
• Measuring peripheral markers of neuroinflammation in Alzheimer's Disease - challenges and opportunities.

  2020cites this paper
• Metabolomics Study of Whole-body Vibration on Lipid Metabolism of Skeletal Muscle in Aging Mice

  2020cites this paper
• 1H-NMR -based metabolic analysis on biocompatibility of dental biomaterials

  2020cites this paper
• Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

  2020cites this paper
• Multicompartmental High-Throughput Metabolomics Based on Mass Spectrometry

  2020cites this paper
• Plasmalogens in the Pathophysiology and Therapy of Age-Specific Diseases

  2020cites this paper
• Motoric cognitive risk syndrome: integration of two early harbingers of dementia in older adults.

  2020cites this paper
• Urinary Biomarkers for Neurodegenerative Diseases

  2020cites this paper
• Current and Developing Methods for Diagnosing Alzheimer's Disease

  2019cites this paper
• Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway

  2019cites this paper
• Serum biomarkers of the calcium-deficient rats identified by metabolomics based on UPLC/Q-TOF MS/MS

  2019cites this paper
• Dysregulated Urinary Arginine Metabolism in Older Adults With Amnestic Mild Cognitive Impairment

  2019cites this paper
• A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential Cancer Biomarkers.

  2019cites this paper
• Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18: 2 Predicts Greater Decline of Gait Speed in Older Adults The Baltimore Longitudinal Study of Aging

  2019cites this paper
• Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.

  2019cites this paper
• A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease

  2019influential citation
• High‐resolution metabolomic profiling of Alzheimer’s disease in plasma

  2019cites this paper
• Metabolic alterations in the outer membrane vesicles of patients with Alzheimer's disease: an LC-MS/MS -based metabolomics analysis.

  2019cites this paper
• Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4-/-: A double-blind, randomized, placebo-controlled crossover trial.

  2019cites this paper
• A review of validated biomarkers obtained through metabolomics

  2018cites this paper
• Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging

  2018cites this paper
• A fingerprinting metabolomic approach reveals deregulation of endogenous metabolites after the intake of a bioactive garlic supplement

  2018cites this paper
• Integration of 1H NMR- and UPLC-Q-TOF/MS-based plasma metabonomics study to identify diffuse axonal injury biomarkers in rat.

  2018cites this paper
• Small molecule biomarkers in Alzheimer’s disease

  2018influential citation
• Metabolism of sleep and aging: Bridging the gap using metabolomics

  2018cites this paper
• Metabolic profiling of the effects of ginsenoside Re in an Alzheimer’s disease mouse model

  2018cites this paper
• The Effect of Chinese Herbal Medicine Formula mKG on Allergic Asthma by Regulating Lung and Plasma Metabolic Alternations

  2017influential citation
• Metabolomics analysis of serum from subjects after occupational exposure to acrylamide using UPLC-MS.

  2017cites this paper
• Metabolomic‐guided discovery of Alzheimer's disease biomarkers from body fluid

  2017cites this paper
• Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.

  2017cites this paper
• Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.

  2016cites this paper
• Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis

  2016cites this paper
• Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study

  2016cites this paper
• Altered Plasma Lysophosphatidylcholines and Amides in Non-Obese and Non-Diabetic Subjects with Borderline-To-Moderate Hypertriglyceridemia: A Case-Control Study

  2015cites this paper
• Recent advances and applications of metabolomics to investigate neurodegenerative diseases.

  2015cites this paper